As we pass the midyear mark, 2025 is already shaping up to be one of digital health’s most validating years in recent memory. IPOs are (finally) back. AI-native tools are showing real-world traction with providers. ...more
In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust...more
10/11/2024
/ Acquisitions ,
Antitrust Provisions ,
Competition ,
Corporate Practice of Medicine ,
Enforcement ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Innovative Technology ,
Med Tech ,
Mergers ,
Non-Compete Agreements ,
Prescription Drugs ,
Public Offerings ,
Vertical Mergers
Rock Health called the landmark Teladoc-Livongo deal a starter pistol for the virtual care platform race. Beyond it being the largest digital health acquisition to date, what significance does this deal hold for the...more
With 58 U.S. biopharma IPOs in 2018, the biotech industry entered the new year with confidence. By all appearances, the longest and largest biotech IPO window in history was not going to close anytime soon. ...more
A few months ago, following our fifth annual Digital Health Summit, the attendees made some predictions about product development and investment in the rapidly growing sector. Now that we are more than halfway through the...more
9/2/2016
/ Acquisitions ,
Digital Health ,
Fitbit ,
Fitness ,
Healthcare ,
Initial Public Offering (IPO) ,
Investors ,
Life Sciences ,
Mergers ,
mHealth ,
Popular ,
Startups ,
Tracking Systems